Vicky M Avery Selected Research

protein-S-isoprenylcysteine O-methyltransferase

10/2013	Solid-phase synthesis of Biotin-S-Farnesyl-L-Cysteine, a surrogate substrate for isoprenylcysteine Carboxylmethyltransferase (ICMT).
6/2008	Small-molecule inhibitors of the cancer target, isoprenylcysteine carboxyl methyltransferase, from Hovea parvicalyx.
12/2007	Spermatinamine, the first natural product inhibitor of isoprenylcysteine carboxyl methyltransferase, a new cancer target.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vicky M Avery Research Topics

Disease

40	Malaria 12/2021 - 05/2010
20	Neoplasms (Cancer) 05/2021 - 12/2007
9	Infections 01/2022 - 01/2013
7	Prostatic Neoplasms (Prostate Cancer) 05/2021 - 11/2012
5	African Trypanosomiasis (Nagana) 01/2017 - 10/2009
4	Breast Neoplasms (Breast Cancer) 01/2021 - 05/2015
4	Chagas Disease (American Trypanosomiasis) 12/2020 - 01/2017
3	Leishmaniasis 01/2022 - 01/2017
3	Parasitemia 01/2021 - 05/2016
3	Carcinoma (Carcinomatosis) 01/2021 - 05/2008
3	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2016 - 07/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 02/2021 - 01/2016
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 05/2008
2	Visceral Leishmaniasis (Kala Azar) 12/2020 - 12/2018
2	Hypoxia (Hypoxemia) 11/2020 - 10/2016
2	Neglected Diseases 01/2017 - 01/2016
2	Trypanosomiasis 11/2016 - 12/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 01/2021
1	Communicable Diseases (Infectious Diseases) 12/2020
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 12/2020
1	Carcinogenesis 10/2019
1	Dehydration (Water Stress) 01/2019
1	Triple Negative Breast Neoplasms 01/2017
1	Multiple Sclerosis 12/2015
1	Multiple Myeloma 12/2015
1	T-Cell Lymphoma (Lymphoma, T Cell) 12/2015
1	Parasitic Diseases (Parasitic Disease) 12/2015

Drug/Important Bio-Agent (IBA)

29	Pharmaceutical PreparationsIBA 01/2022 - 10/2009
14	Antimalarials (Antimalarial Agents)IBA 11/2021 - 01/2012
10	Chloroquine (Aralen)FDA LinkGeneric 10/2021 - 12/2010
5	Histone Deacetylase InhibitorsIBA 10/2018 - 07/2014
3	NitroimidazolesIBA 12/2020 - 12/2018
3	pretomanidIBA 12/2020 - 12/2018
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 11/2012
3	protein-S-isoprenylcysteine O-methyltransferaseIBA 10/2013 - 12/2007
2	Coloring Agents (Dyes)IBA 01/2022 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2021 - 01/2018
2	OPC-67683IBA 12/2020 - 12/2018
2	EnzymesIBA 11/2020 - 07/2015
2	AndrogensIBA 09/2020 - 10/2019
2	Androgen Receptors (Androgen Receptor)IBA 09/2020 - 10/2019
2	Complex MixturesIBA 07/2019 - 01/2017
2	Antiparasitic Agents (Antiparasitics)IBA 01/2019 - 04/2015
2	Histone Deacetylases (Histone Deacetylase)IBA 10/2018 - 07/2014
2	IntegrinsIBA 01/2018 - 10/2013
2	SC83288IBA 01/2017 - 01/2017
2	Biological ProductsIBA 12/2015 - 12/2007
2	LigandsIBA 10/2013 - 01/2009
2	Chemokine ReceptorsIBA 10/2013 - 01/2009
1	Culture MediaIBA 01/2022
1	Amyloidogenic ProteinsIBA 01/2022
1	SynucleinsIBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	QuinazolinesIBA 12/2021
1	ArtesunateIBA 10/2021
1	Phenol (Carbolic Acid)FDA Link 10/2021
1	methyl 2-(-5-fluoro-2-hydroxyphenyl)-1 H-benzo(d)imidazole-5-carboxylateIBA 05/2021
1	PuromycinIBA 05/2021
1	PiperazineIBA 03/2021
1	TriazinesIBA 01/2021
1	Hemin (Panhematin)FDA Link 11/2020
1	InterferonsIBA 11/2020
1	MyoglobinIBA 11/2020
1	Glucose (Dextrose)FDA LinkGeneric 09/2020
1	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 01/2020
1	Capsaicin (Zostrix)FDA Link 10/2019
1	sulforaphaneIBA 10/2019
1	cleistenolideIBA 07/2019
1	dichamanetinIBA 07/2019
1	Indigo Carmine (Indigo Blue)IBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	benzonidazole (benznidazole)IBA 01/2019
1	PeptoidsIBA 10/2018
1	Extracellular Matrix ProteinsIBA 01/2018
1	ThioredoxinsIBA 10/2016
1	Auranofin (Ridaura)FDA Link 10/2016
1	Oxygen (Dioxygen)IBA 10/2016
1	hemozoinIBA 05/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Fingolimod Hydrochloride (FTY720)FDA Link 12/2015
1	SphingolipidsIBA 12/2015
1	PanobinostatIBA 12/2015
1	Vorinostat FDA Link 12/2015
1	romidepsin (FK228)FDA Link 12/2015
1	belinostatIBA 12/2015
1	DSM265IBA 07/2015
1	Drug CombinationsIBA 07/2015
1	pyrimidineIBA 07/2015
1	Dihydroorotate DehydrogenaseIBA 07/2015
1	Epirubicin (Ellence)FDA LinkGeneric 05/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2015
1	Vinorelbine (Navelbine)FDA LinkGeneric 05/2015
1	Dihydrotachysterol (AT 10)IBA 04/2015
1	LipidsIBA 04/2015
1	Phospholipids (Phosphatides)FDA LinkGeneric 04/2015

Therapy/Procedure

15	Therapeutics 01/2022 - 09/2013
1	Oral Administration 01/2019